THERAPEUTIC APPROACHES TO THE URTICARIA TREATMENT



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Urticaria is a heterogenic disorder, requires elimination of triggers and symptomatic treatment. The basic medications are antihistaminics of the second generation.

Full Text

Restricted Access

About the authors

S M Shvets

Institute of Immunology

Email: smshvets@gmail.com
Moscow, Russia

References

  1. EAACI/GA2LEN/EDF/WAO guideline: management of urticaria Allergy. 2009, v. 64, р. 1427-1443.
  2. Российский национальный согласительный документ. Крапивница и ангиоотек. Рекомендации для практических врачей. М., «Фармарус Принт Медиа», 2007, 128 с.
  3. EAACI/GA2LEN/EDF guideline: management of urticaria Allergy. 2006, v. 61, p. 321-331.
  4. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009, v. 64, р. 1417-1426.
  5. Church M.K., Mauer M., Simons F.E. et Risk of first-generation H,-antihistamines: a GA2LEN position paper. Allergy 2010, v. 65, p. 459-466.
  6. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М., «Фармарус Принт». 1998, 252 с.
  7. Gillman S., Gillard M., Strolin Benedetti M. The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H,-antihistamines. Allergy Asthma Proc. 2009, v. 30 (4), p. 366-376.
  8. Jauregui I., Ferrer M., Montoro L. et al. Anyihistamines in the treatment of chronic urticaria. J. Investig. Allergol. Clin. Immunol. 2007, v. 17, Suppl. 2, p. 41-52.
  9. Nettis E., Colanardi M.C., Barra L. et al. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. J. Dermatol. 2006, v. 154 (3), p. 533-538.
  10. Potter P.C., Kapp A., Maurer M. et al. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Allergy. 2009, v. 64 (4), p. 596-604.

Copyright © Pharmarus Print Media, 2012



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies